← Back to Clinical Trials
Recruiting NCT06113042

NCT06113042 KeySteps@JC Phase Two Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06113042
Status Recruiting
Phase
Sponsor The University of Hong Kong
Condition Lifestyle Modification
Study Type INTERVENTIONAL
Enrollment 6,000 participants
Start Date 2023-11-01
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Health talks, learning packsLifestyle modification programmeSchool healthy environment evaluation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 6,000 participants in total. It began in 2023-11-01 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This proposed 'KeySteps Phase Two Study' is a 5-year study, which aims to investigate the effectiveness and sustainability of a Community Child Health Model with different services related to healthy lifestyle programmes and health promotion implemented in community settings of deprived living areas. Potential participants are children studying or living in the five selected districts, namely Sham Shui Po, Yuen Long, Tuen Mun, Sha Tin and Kowloon City. Data including children's health and psychosocial conditions, and family demographics will be collected. In addition, subjects will receive on-site assessments on general health and development. Medical and health related events of subjects will be tracked through the existing health care system. Subjects will receive health promotion services and/or lifestyle modification programmes according to their needs.

Eligibility Criteria

Inclusion Criteria: 1. Children are studying in kindergartens which agree to join the project. 2. Parent/legal guardian of the child consented the child's participation in to the study. 3. Participants of the Lifestyle modification Programme should be K1 students in academic year 2023/24 of the selected kindergartens and their parents/guardians. Exclusion Criteria: 1. Parent/legal guardian of the child cannot understand Cantonese. 2. Parent/legal guardian of the child cannot read Chinese.

Contact & Investigator

Central Contact

Patrick IP, MPH

✉ patricip@hku.hk

📞 +852 22554090

Principal Investigator

Patrick IP, MPH

PRINCIPAL INVESTIGATOR

The University of Hong Kong

Frequently Asked Questions

Who can join the NCT06113042 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, studying Lifestyle Modification. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06113042 currently recruiting?

Yes, NCT06113042 is actively recruiting participants. Contact the research team at patricip@hku.hk for enrollment information.

Where is the NCT06113042 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT06113042 clinical trial?

NCT06113042 is sponsored by The University of Hong Kong. The principal investigator is Patrick IP, MPH at The University of Hong Kong. The trial plans to enroll 6,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology